Tower Research Capital LLC (TRC) - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 31 filers reported holding IMMUCELL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUCELL CORP
ValueSharesWeighting
Q3 2023$8,731
-60.3%
1,635
-62.9%
0.00%
-100.0%
Q2 2023$22,010
+183316.7%
4,402
+88.5%
0.00%
Q1 2023$12
+50.0%
2,335
+83.0%
0.00%
Q4 2022$8
-99.2%
1,276
+734.0%
0.00%
Q2 2022$1,0000.0%153
+53.0%
0.00%
Q4 2021$1,000
-75.0%
100
-76.5%
0.00%
Q2 2021$4,000
-42.9%
426
-42.9%
0.00%
Q1 2021$7,000
+600.0%
746
+309.9%
0.00%
Q4 2020$1,000
-50.0%
182
-40.7%
0.00%
Q3 2020$2,000
-77.8%
307
-82.7%
0.00%
-100.0%
Q4 2019$9,000
+80.0%
1,773
+111.8%
0.00%
Q3 2019$5,000837
+1295.0%
0.00%
Q2 2019$0
-100.0%
60
-91.6%
0.00%
Q1 2019$5,000
+25.0%
715
+31.9%
0.00%
Q4 2018$4,000
+100.0%
542
+83.7%
0.00%
Q3 2018$2,000
+100.0%
295
+75.6%
0.00%
Q2 2018$1,000168
+217.0%
0.00%
Q4 2017$053
-10.2%
0.00%
Q2 2017$0
-100.0%
59
-89.0%
0.00%
Q1 2017$3,000
-25.0%
537
-2.5%
0.00%
Q3 2016$4,000
+100.0%
551
+67.0%
0.00%
Q2 2016$2,000
-60.0%
330
-52.9%
0.00%
-100.0%
Q1 2016$5,0000.0%700
-12.4%
0.00%
Q3 2015$5,000
-28.6%
799
-3.9%
0.00%
-100.0%
Q2 2015$7,000
+75.0%
831
+19.2%
0.00%
Q1 2015$4,0000.0%697
-16.0%
0.00%
Q4 2014$4,000
+300.0%
830
+698.1%
0.00%
Q3 2014$1,0000.0%104
-59.7%
0.00%
Q2 2014$1,000258
+3585.7%
0.00%
Q1 2014$0
-100.0%
7
-99.1%
0.00%
-100.0%
Q4 2013$3,000
+200.0%
783
+208.3%
0.00%
Q2 2013$1,0002540.00%
Other shareholders
IMMUCELL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Financial Services, Inc. 23,776$89,0000.03%
SHUFRO ROSE & CO LLC 51,263$192,0000.02%
Tower Research Capital LLC (TRC) 254$1,0000.00%
Creative Planning 310$1,0000.00%
Renaissance Technologies 10,000$38,0000.00%
UBS AG 1,870$7,0000.00%
US BANCORP \DE\ 24$00.00%
BANK OF AMERICA CORP /DE/ 2,032$8,0000.00%
WELLS FARGO & COMPANY/MN 1$00.00%
MORGAN STANLEY 29,628$111,0000.00%
View complete list of IMMUCELL CORP shareholders